‘A Great Deal of Illusory Risk’: Sell Broadcom | $AVGO

12/28/16 07:44AM EST

https://youtu.be/QvaId0Yt8fo

Broadcom (AVGO) is a Wall Street darling. That might not last much longer.

The $71 billion smartphone chip maker has masked a downturn in business by going on a multi-billion dollar spending spree. The company merged with rival Avago, in 2015, in a deal worth $37 billion. It recently purchased Brocade for $5.5 billion. Management did a good job selling these deals to investors.

The stock is up +30% this year.

Hedgeye Technology analyst Ami Joseph think the outlook for Broadcom doesn’t look good. In the video excerpt above, Joseph had this to say about Broadcom:

“What we don’t like is this is a cyclical asset that is modeled in secular terms with an M&A machine that obfuscates underlying growth. It’s a machine in which, you appear to exhibit control over your own destiny, but we think creates a great deal of illusory risk. This is the reason why the sentiment around the stock is so one-sided, in terms of sell-side ratings and short interest in the stock.”

But the company can’t mask the underlying weakness of its cyclical business forever, Joseph says. “As we roll forward organically I think you’re going to see some pressure on the top-line which is obviously going to change everyone’s view,” he says.

Watch the video above to see why we don’t like the stock.

© 2024 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.